FDA Approves Esketamine Nasal Spray as Standalone Treatment for Depression

FDA Approves Esketamine Nasal Spray as Standalone Treatment for Depression

FDA Approves Spravato Nasal Spray‍ as Standalone Treatment for Major ⁢Depressive Disorder In a groundbreaking move, the U.S. food and Drug Governance (FDA) has approved a supplemental‌ new drug request for Spravato (esketamine) nasal spray, allowing it to be used as ⁤a standalone treatment for adults with major depressive⁢ disorder (MDD) who have not responded … Read more

FDA Recalls Antidepressant Duloxetine: What You Need to Know

FDA Recalls Antidepressant Duloxetine: What You Need to Know

Major Recall of Antidepressant ⁤Cymbalta Due to Cancer-Causing Impurity Table of Contents Major Recall of Antidepressant ⁤Cymbalta Due to Cancer-Causing Impurity What to Do If You⁢ Have Recalled​ Cymbalta Understanding SNRIs: A Guide for US Readers How‍ SNRIs Work: A Closer Look Duloxetine⁣ (Cymbalta): A Common ⁢SNRI Importance of Professional ⁣Guidance Nitrosamines in Food: Understanding … Read more